GILEAD SCIENCES, INC. bought RCUS

January 29, 2024 · Form 4 insider transaction

GILEAD SCIENCES, INC. bought 15,238,095 shares of Arcus Biosciences, Inc. at $21.00 per share, a transaction worth $320.00M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.